Eureka Biotech Call 2026

6 May – 25 Sept 2026

Centro de Investigación e Innovación Biomédica

University

www.uandes.cl/centros/ciib/Santiago, Chile
1 profile visit

About

The Center for Research and Innovation in Biomedicine (CiiB) at Universidad de los Andes (UANDES), Chile, is a multidisciplinary biomedical research center focused on translating scientific discoveries into clinically relevant technologies and innovative healthcare solutions.

CiiB combines expertise in molecular and cellular biology, cardiovascular and renal medicine, extracellular vesicles, biomarker discovery, omics, imaging, and data-driven biomedical research. Its infrastructure supports experimental development, human sample analysis, biomarker validation, and preclinical and translational studies.

A key strength of CiiB is its capacity to bridge academic research with clinical applications through collaborations with hospitals, healthcare institutions, and industry. The Center actively supports technology development, intellectual property generation, clinical validation, and technology transfer, enabling promising discoveries to progress from proof-of-concept toward higher technology readiness levels and future commercialization.

Within CORFO–EUREKA, CiiB can provide scientific and technological expertise, advanced biomedical infrastructure, biomarker development and validation capabilities, and access to clinical research networks, contributing to the development and validation of innovative health technologies in collaboration with international industry partners.

Social media

Areas of activity

Next-generation therapeutics and modalities

Innovative cancer treatment modalitiesMicrobiome-based therapies and diagnosticsExosome-based therapies and delivery systemsNeuroscience-focused modalities

Advanced diagnostics and data technologies

Advanced bioinformatics and artificial intelligence for biotechnologyOn-site molecular diagnostics

Representatives

Principal Investigator

Centro de Investigación e Innovación Biomédica

Marketplace (1)

  • Project cooperation

    Biomarkers of cardiovascular risk diseases

    CARDIO-EV+ is a translational platform integrating extracellular vesicle biomarkers, microbiome profiles, and AI to predict cardiovascular dysfunction and cardiotoxicity, enabling earlier risk stratification and personalized patient management.

    • Completing the consortia
    • Project idea is seeking partners
    • Advanced diagnostics and data technologies
    Author

    Principal Investigator at Centro de Investigación e Innovación Biomédica

    Santiago, Chile